Examining the role of perivascular fibroblasts in cerebral amyloid angiopathy during Alzheimers disease

NIH RePORTER · NIH · R21 · $196,875 · view on reporter.nih.gov ↗

Abstract

ABSTRACT Alzheimer's disease (AD) is a debilitating, chronic neurodegenerative disease that is the most common form of dementia. The pathophysiology of AD includes the progressive loss of neurons and synapses throughout the cerebral cortex as well as subcortical regions, and is characterized by the buildup of amyloid-beta (Aβ) plaques and tau-containing neurofibrillary tangle pathologies throughout these regions. Aβ plaques have been reported to be associated with neuronal and glial cells (parenchymal plaques), or associated with blood vessels (vascular plaques termed cerebral amyloid angiopathy [CAA]). CAA is found in up to 90% of patients with AD, and is thought to lead to impaired blood flow, altered vascular morphology, inflammation, microbleeds and hemorrhage. Despite the importance of CAA, very little is known about how Aβ deposits around vessels. There are two main hypotheses: First, vascular plaques are generated through the aberrant secretion of Aβ by endothelial cells and/or mural cells. Second, vascular plaques are generated though dysfunction in clearance of Aβ. Here we test a novel hypothesis: perivascular fibroblasts secrete Aβ in the generation of CAA. Work in our lab has identified that perivascular fibroblasts are intimately associated with vascular Aβ plaques in AD postmortem tissue. We have also identified that that perivascular fibroblasts robustly express amyloid precursor protein (APP) and the enzymes that process amyloid (BACE1/2, PSEN1). Here, we will use a conditional knockout approach to determine whether fibroblasts are the key cell type that secretes Aβ in the generation of CAA in a well characterized mouse model of AD. We will also utilize single cell sequencing to examine the cellular heterogeneity and gene expression of the perivascular fibroblasts as a function of time in the mouse AD model. If we find that perivascular fibroblasts are key contributors to Aβ secretion in the buildup of CAA, then this analysis will give insights into to the mechanism that leads to this vascular Aβ accumulation. If we find that fibroblast secretion of Aβ is not necessary for the generation of CAA, this analysis will provide vital information about how the fibroblasts change during the formation of vascular Aβ plaques, with which they are intimately associated.

Key facts

NIH application ID
9897476
Project number
5R21AG062918-02
Recipient
UNIVERSITY OF CALIFORNIA, SAN DIEGO
Principal Investigator
Richard Daneman
Activity code
R21
Funding institute
NIH
Fiscal year
2020
Award amount
$196,875
Award type
5
Project period
2019-04-01 → 2022-01-31